Top compounds associated with response to RP11-613M10.9


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.15 7e-05
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.0007
mRNA YM-155 CTRPv2 pan-cancer AAC 0.13 0.0009
mRNA AZD1480 CTRPv2 pan-cancer AAC -0.17 0.001
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.002
mRNA SR1001 CTRPv2 pan-cancer AAC -0.11 0.003
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.13 0.004
mRNA thalidomide CTRPv2 pan-cancer AAC -0.15 0.004
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.13 0.005
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.088 0.006
Download CSV